(Q35071444)

6 August 2017

1 reference

title

HIV-1 cell entry and advances in viral entry inhibitor therapy (English)

1 reference

6 August 2017

Sharon R Lewin

2

0 references

author name string

Louise A Cooley

series ordinal

1

1 reference

6 August 2017

1 February 2003

1 reference

Journal of Clinical Virology

6 August 2017

1 reference

6 August 2017

26

1 reference

6 August 2017

2

1 reference

6 August 2017

121-132

1 reference

Expression and Characterization of CD4-IgG2, a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Oligomerization of the hydrophobic heptad repeat of gp41.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Human immunodeficiency virus type 1 entry inhibitors PRO 542 and T-20 are potently synergistic in blocking virus-cell and cell-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Protein design of an HIV-1 entry inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

HIV gp120: double lock strategy foils host defences

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

HIV gp120 receptors on human dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900111-7

7 January 2021

10.1016/S1386-6532(02)00111-7

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12600644